NCT04647630 Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
| NCT ID | NCT04647630 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Community-acquired Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,800 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,800 participants in total. It began in 2021-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an epidemiology study for the prevalence and serotypes of pneumococcus pneumoniae in hospitalized patients with community acquired pneumonia (CAP). The serotypes of the pneumococcus pneumoniae will be determined by a urinary antigen assay. This is a single center, non-interventional observatory study.
Eligibility Criteria
Inclusion Criteria: * Admitted with signs and symptoms suggestive of pneumonia Exclusion Criteria: * 1\. Nosocomial pneumonia which is acquired \>= 48 hours after hospital admission. 2. Pneumonia which are already known to be caused by pathogens other than pneumococcus pneumoniae.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04647630 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Community-acquired Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04647630 currently recruiting?
Yes, NCT04647630 is actively recruiting participants. Contact the research team at tokw617@yahoo.com.hk for enrollment information.
Where is the NCT04647630 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT04647630 clinical trial?
NCT04647630 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 1,800 participants.